These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3325753)

  • 1. The use of in vivo-like concentrations of chemicals for validation of in vitro short-term genotoxicity assays--an in vivo equivalent dose concept.
    Dashwood RH; Combes RD
    Mutagenesis; 1987 Jul; 2(4):249-51. PubMed ID: 3325753
    [No Abstract]   [Full Text] [Related]  

  • 2. International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC publication No. 16. Testing for mutagens and carcinogens; the role of short-term genotoxicity assays.
    Mutat Res; 1988; 205(1-4):3-12. PubMed ID: 3285192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prospects for a simplified and internationally harmonized approach to the detection of possible human carcinogens and mutagens.
    Ashby J
    Mutagenesis; 1986 Jan; 1(1):3-16. PubMed ID: 3325732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic toxicology: can we design predictive in vivo assays?
    Clive D
    Mutat Res; 1988; 205(1-4):313-30. PubMed ID: 3285193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A carcinogens--methods for detecting environmental muta/carcinogens].
    Morimoto K; Koizumi A
    Gan To Kagaku Ryoho; 1985 Apr; 12(4):789-97. PubMed ID: 3885860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A core in vitro genotoxicity battery comprising the Ames test plus the in vitro micronucleus test is sufficient to detect rodent carcinogens and in vivo genotoxins.
    Kirkland D; Reeve L; Gatehouse D; Vanparys P
    Mutat Res; 2011 Mar; 721(1):27-73. PubMed ID: 21238603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there a continuing role for the intraperitoneal injection route of exposure in short-term rodent genotoxicity assays?
    Ashby J
    Mutat Res; 1985 Jun; 156(3):239-43. PubMed ID: 4000180
    [No Abstract]   [Full Text] [Related]  

  • 8. Short-term tests for defining mutagenic carcinogens.
    Waters MD; Stack HF; Jackson MA
    IARC Sci Publ; 1999; (146):499-536. PubMed ID: 10353401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutagenicity testing for chemical risk assessment: update of the WHO/IPCS Harmonized Scheme.
    Eastmond DA; Hartwig A; Anderson D; Anwar WA; Cimino MC; Dobrev I; Douglas GR; Nohmi T; Phillips DH; Vickers C
    Mutagenesis; 2009 Jul; 24(4):341-9. PubMed ID: 19535363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term tests and the myth of the non-clastogenic mutagen.
    Green MH
    Mutagenesis; 1988 Sep; 3(5):369-71. PubMed ID: 3070270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM Workshop.
    Kirkland D; Pfuhler S; Tweats D; Aardema M; Corvi R; Darroudi F; Elhajouji A; Glatt H; Hastwell P; Hayashi M; Kasper P; Kirchner S; Lynch A; Marzin D; Maurici D; Meunier JR; Müller L; Nohynek G; Parry J; Parry E; Thybaud V; Tice R; van Benthem J; Vanparys P; White P
    Mutat Res; 2007 Mar; 628(1):31-55. PubMed ID: 17293159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens II. Further analysis of mammalian cell results, relative predictivity and tumour profiles.
    Kirkland D; Aardema M; Müller L; Makoto H
    Mutat Res; 2006 Sep; 608(1):29-42. PubMed ID: 16769241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro metabolic activation in genotoxicity assays with mammalian cell cultures.
    Belvedere G
    Boll Chim Farm; 1985 Feb; 124(2):57-68. PubMed ID: 4015867
    [No Abstract]   [Full Text] [Related]  

  • 14. Predicting the carcinogenicity of the aromatic amine derivatives tested in the second UKEMS Collaborative Study.
    Ennever FK; Rosenkranz HS
    Mutagenesis; 1986 Mar; 1(2):119-23. PubMed ID: 3146010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.
    Kirkland D; Aardema M; Henderson L; Müller L
    Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of the in vitro transgene mutation assay in MutaMouse FE1 cells: Evaluation of nine misleading ("False") positive chemicals.
    Maertens RM; Long AS; White PA
    Environ Mol Mutagen; 2017 Oct; 58(8):582-591. PubMed ID: 28843037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clastogenicity of chemicals in cultured mammalian cells.
    Ishidate M; Harnois MC
    Mutagenesis; 1987 May; 2(3):240-3. PubMed ID: 3325752
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of in vivo/in vitro unscheduled DNA synthesis for identification of organ-specific carcinogens.
    Furihata C; Matsushima T
    Crit Rev Toxicol; 1987; 17(3):245-77. PubMed ID: 3556021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of carcinogenic potency by short-term genotoxicity tests.
    Ennever FK; Rosenkranz HS
    Mutagenesis; 1987 Jan; 2(1):39-44. PubMed ID: 3331693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro testing for carcinogens and mutagens.
    Santella RM
    Occup Med; 1987; 2(1):39-46. PubMed ID: 3306977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.